Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
HENLIUS
HENLIUS (02696.HK): NMPA Clears HLX105 Phase 1 Solid Tumour IND
Tags:
HENLIUS
02696.HK
NewTimeSpace
2026-11-16
HK Stock Connect Insight | HENLIUS (02696.HK) First-Half Net Profit Up 10.3% YoY, Included in Stock Connect from September 7
Tags:
HENLIUS
02696.HK
HK Stock Connect
2026-10-30
HENLIUS (02696.HK): Inks Deal with Amberstone on Two TCE Products
Tags:
HENLIUS
02696.HK
Licence Agreement
2026-09-23
New round of southbound Stock Connect target adjustments: 54 added, 15 removed
Tags:
Stock Connect
HARBIN ELECTRIC
HENLIUS
MING YUAN CLOUD
NISSIN FOODS
2026-09-07
HENLIUS (02696.HK): Included in Stock Connect eligible securities list effective 7 September
Tags:
HENLIUS
02696.HK
Stock Connect
2026-09-07
HENLIUS (02696.HK): Added as Hang Seng Composite Index Constituent, Effective 7 September
Tags:
HENLIUS
02696.HK
Hang Seng Composite Index
2026-08-21
Going Global Weekly Report: Pharma Overseas Expansion Blossoms Across Fronts, A-Share Companies Accelerate Hong Kong Listings - 20260821
Tags:
Going Global Weekly Report
HENLIUS
SINOPEC SSC
INGENIC
HAIXI PHARMA
2026-08-21
HENLIUS (02696.HK): enters global strategic partnership with Sandoz covering up to 10 biosimilar products, with upfront and milestone payments totaling up to USD 314 million
Tags:
HENLIUS
02696.HK
strategic cooperation
2026-08-17
Henlius (02696.HK): NMPA Approves Clinical Trial Application for HLX43 Combined with Bevacizumab in Solid Tumors
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-07-31
Henlius (02696.HK): First Patient Dosed in Phase 1 Trial of Trispecific Antibody HLX3902 Targeting STEAP1×CD3×CD28
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-07-30
HENLIUS (02696.HK): Biosimilar HLX18 to Nivolumab Doses First Patient in China for Global Multi-centre Phase I Trial
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-07-16
HENLIUS (02696.HK): NMPA Approves Phase I Trial for HLX37 (PD-L1/VEGF Bispecific) Plus Chemotherapy or HLX43 (PD-L1 ADC) in Solid Tumours
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-07-10
HENLIUS(02696.HK): First Patient Dosed in Phase I Clinical Trial of HLX05-N, a Cetuximab Biosimilar, for Metastatic Colorectal Cancer
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-07-08
HENLIUS(02696.HK): Bispecific EGFR/c-MET ADC HLX48 Doses First Patient
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-06-30
Henlius (02696.HK) Serplulimab Approved by EU Commission for First-Line sqNSCLC
Tags:
HENLIUS
02696.HK
Innovative Drugs
2026-06-25
Henlius(02696.HK): HLX3902 Injection (STEAP1xCD3xCD28 Trispecific Antibody) Gets NMPA Approval for Phase I Clinical Trial in Metastatic Castration-Resistant Prostate Cancer
Tags:
HENLIUS
02696.HK
Investigational New Drug application
2026-06-17
Henlius(02696.HK): Hanbeiyou (Pertuzumab Injection) Passes GMP Compliance Inspection, Songjiang Base Eligible for Commercial Production
Tags:
HENLIUS
02696.HK
GMP compliance inspection
2026-06-17
Henlius(02696.HK):Phase 2 Clinical Trial of HLX43 Combined with Serplulimab for Neoadjuvant Treatment of NSCLC Approved in Australia
Tags:
HENLIUS
02696.HK
HLX43
Clinical Trial
2026-06-16
HENLIUS(02696.HK): HLX04-O Meets Primary Endpoint in Global Multicenter Phase 3 Trial for Wet Age-Related Macular Degeneration
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-06-16
HENLIUS(02696.HK): Hanbeiyou (Pertuzumab Injection) Approved by NMPA for HER2-positive Breast Cancer Treatment
Tags:
HENLIUS
02696.HK
New Drug Marketing Application
2026-05-29
1
2
Next
Finance
METIS TECHBIO-P (07666.HK): plans H-share buyback of up to HKD 300m
Finance
HENGRUI PHARMA (01276.HK): hetrombopag NDA accepted in China
Research
HK Stock Connect Daily: NETEASE -17.60% on Gaming Slump - 20261120
Finance
WATER OASIS GP (01161.HK): FY profit seen doubling to HKD 165-175m
Research
HK AI Concept Stock Daily: BABA-W +3.48% Defies Slump - 20261120
Research
Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Rises 39.50% to Lead; Intelligent Driving and Smart Parking Gain Traction-20261120
Finance
NewTimeSpace | HK Close: HSI -1.89%, Semis and Hardware Lead Declines
Research
HK shares ETFs Daily Report: Fubon Taiwan Semiconductor ETF Falls 9.81% as CSI 300 and India Themes Rise-Nov 20, 2026
Research
Offshore Trust Insight | NIO-SW (09866.HK) -5.07%; Users Trust 50m
Research
HK Stock Connect Insight | RA MATERIALS (09607.HK) -13.26%; Stake Rise
Scan QR Code
Download App